Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading higher by 9.66% to $15.72 Thursday morning after the company reported better-than-expected fourth-quarter results.
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy
Bolsters Presence in Neuroscience
Expected to be Accretive in 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday.
The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. The S&P 500 also rose, gaining, 0.85% to 4,006.43.
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
Announced Earlier Today-Notice Received from ANDA Filer for FIRDAPSE®
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday.
The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500 also rose, gaining, 1.31% to 4,024.60.